<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35448898</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2072-6651</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>16</Day>
            </PubDate>
          </JournalIssue>
          <Title>Toxins</Title>
          <ISOAbbreviation>Toxins (Basel)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>New Mutants of Epsilon Toxin from <i>Clostridium perfringens</i> with an Altered Receptor-Binding Site and Cell-Type Specificity.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">288</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/toxins14040288</ELocationID>
        <Abstract>
          <AbstractText>Epsilon toxin (Etx) from <i>Clostridium perfringens</i> is the third most potent toxin after the botulinum and tetanus toxins. Etx is the main agent of enterotoxemia in ruminants and is produced by <i>Clostridium perfringens</i> toxinotypes B and D, causing great economic losses. Etx selectively binds to target cells, oligomerizes and inserts into the plasma membrane, and forms pores. A series of mutants have been previously generated to understand the cellular and molecular mechanisms of the toxin and to obtain valid molecular tools for effective vaccination protocols. Here, two new non-toxic Etx mutants were generated by selective deletions in the binding (Etx-ΔS188-F196) or insertion (Etx-ΔV108-F135) domains of the toxin. As expected, our results showed that Etx-ΔS188-F196 did not exhibit the usual Etx binding pattern but surprisingly recognized specifically an O-glycoprotein present in the proximal tubules of the kidneys in a wide range of animals, including ruminants. Although diminished, Etx-ΔV108-F135 maintained the capacity for binding and even oligomerization, indicating that the mutation particularly affected the pore-forming ability of the toxin.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dorca-Arévalo</LastName>
            <ForeName>Jonatan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Campus of Bellvitge, University of Barcelona, Hospitalet de Llobregat, 08907 Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Institute of Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gómez de Aranda</LastName>
            <ForeName>Inmaculada</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Campus of Bellvitge, University of Barcelona, Hospitalet de Llobregat, 08907 Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blasi</LastName>
            <ForeName>Juan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Campus of Bellvitge, University of Barcelona, Hospitalet de Llobregat, 08907 Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Institute of Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Neurosciences, University of Barcelona, 08035 Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Toxins (Basel)</MedlineTA>
        <NlmUniqueID>101530765</NlmUniqueID>
        <ISSNLinking>2072-6651</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003016" MajorTopicYN="Y">Clostridium perfringens</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004767" MajorTopicYN="Y">Enterotoxemia</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Clostridium perfringens</Keyword>
        <Keyword MajorTopicYN="N">MDCK cells</Keyword>
        <Keyword MajorTopicYN="N">N-glycosidase F</Keyword>
        <Keyword MajorTopicYN="N">enterotoxemia</Keyword>
        <Keyword MajorTopicYN="N">epsilon toxin</Keyword>
        <Keyword MajorTopicYN="N">lectin</Keyword>
        <Keyword MajorTopicYN="N">pronase E</Keyword>
        <Keyword MajorTopicYN="N">proximal tubules</Keyword>
        <Keyword MajorTopicYN="N">pulpy kidney disease</Keyword>
        <Keyword MajorTopicYN="N">β-elimination</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>20</Hour>
          <Minute>20</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35448898</ArticleId>
        <ArticleId IdType="pmc">PMC9031233</ArticleId>
        <ArticleId IdType="doi">10.3390/toxins14040288</ArticleId>
        <ArticleId IdType="pii">toxins14040288</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bokori-Brown M., Kokkinidou M., Savva C., da Costa S., Naylor C., Cole A., Moss D., Basak A., Titball R. Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies. Protein Sci. 2013;22:650–659. doi: 10.1002/pro.2250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pro.2250</ArticleId>
            <ArticleId IdType="pmc">PMC3649266</ArticleId>
            <ArticleId IdType="pubmed">23504825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rood J., Cole S. Molecular-genetics and pathogenesis of Clostridium perfringens. Microbiol. Rev. 1991;55:621–648. doi: 10.1128/mr.55.4.621-648.1991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mr.55.4.621-648.1991</ArticleId>
            <ArticleId IdType="pmc">PMC372840</ArticleId>
            <ArticleId IdType="pubmed">1779929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Payne D., Oyston P.  In: The Clostridium Perfringens Epsilon Toxin. Rood J.I., editor. Academic Press; San Diego, CA, USA: 1997. </Citation>
        </Reference>
        <Reference>
          <Citation>Minami J., Katayama S., Matsushita O., Matsushita C., Okabe A. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides. Microbiol. Immunol. 1997;41:527–535. doi: 10.1111/j.1348-0421.1997.tb01888.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1348-0421.1997.tb01888.x</ArticleId>
            <ArticleId IdType="pubmed">9272698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Popoff M.R. Epsilon toxin: A fascinating pore-forming toxin. FEBS J. 2011;278:4602–4615. doi: 10.1111/j.1742-4658.2011.08145.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1742-4658.2011.08145.x</ArticleId>
            <ArticleId IdType="pubmed">21535407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goldstein J., Morris W.E., Loidl C.F., Tironi-Farinati C., Tironi-Farinatti C., McClane B.A., Uzal F.A., Fernandez Miyakawa M.E. Clostridium perfringens epsilon toxin increases the small intestinal permeability in mice and rats. PLoS ONE. 2009;4:e7065.  doi: 10.1371/journal.pone.0007065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0007065</ArticleId>
            <ArticleId IdType="pmc">PMC2739291</ArticleId>
            <ArticleId IdType="pubmed">19763257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adamson R.H., Ly J.C., Fernandez-Miyakawa M., Ochi S., Sakurai J., Uzal F., Curry F.E. Clostridium perfringens epsilon-toxin increases permeability of single perfused microvessels of rat mesentery. Infect. Immun. 2005;73:4879–4887. doi: 10.1128/IAI.73.8.4879-4887.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.73.8.4879-4887.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1201274</ArticleId>
            <ArticleId IdType="pubmed">16041001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uzal F.A., Songer J.G. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J. Vet. Diagn. Investig. 2008;20:253–265. doi: 10.1177/104063870802000301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/104063870802000301</ArticleId>
            <ArticleId IdType="pubmed">18460610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nagahama M., Sakurai J. Distribution of labeled Clostridium perfringens epsilon toxin in mice. Toxicon. 1991;29:211–217. doi: 10.1016/0041-0101(91)90105-Z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0041-0101(91)90105-Z</ArticleId>
            <ArticleId IdType="pubmed">2048139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soler-Jover A., Dorca J., Popoff M.R., Gibert M., Saura J., Tusell J.M., Serratosa J., Blasi J., Martín-Satué M. Distribution of Clostridium perfringens epsilon toxin in the brains of acutely intoxicated mice and its effect upon glial cells. Toxicon. 2007;50:530–540. doi: 10.1016/j.toxicon.2007.04.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.toxicon.2007.04.025</ArticleId>
            <ArticleId IdType="pubmed">17572464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adler D., Linden J., Shetty S., Ma Y., Bokori-Brown M., Titball R., Vartanian T. Clostridium perfringens Epsilon Toxin Compromises the Blood-Brain Barrier in a Humanized Zebrafish Model. Iscience. 2019;15:39–54. doi: 10.1016/j.isci.2019.04.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.isci.2019.04.016</ArticleId>
            <ArticleId IdType="pmc">PMC6487375</ArticleId>
            <ArticleId IdType="pubmed">31030181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorca-Arevalo J., Pauillac S., Diaz-Hidalgo L., Martin-Satue M., Popoff M.R., Blasi J. Correlation between In Vitro Cytotoxicity and In Vivo Lethal Activity in Mice of Epsilon Toxin Mutants from Clostridium perfringens. PLoS ONE. 2014;9:e102417.  doi: 10.1371/journal.pone.0102417.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0102417</ArticleId>
            <ArticleId IdType="pmc">PMC4094505</ArticleId>
            <ArticleId IdType="pubmed">25013927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorca-Arévalo J., Soler-Jover A., Gibert M., Popoff M.R., Martín-Satué M., Blasi J. Binding of epsilon-toxin from Clostridium perfringens in the nervous system. Vet. Microbiol. 2008;131:14–25. doi: 10.1016/j.vetmic.2008.02.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetmic.2008.02.015</ArticleId>
            <ArticleId IdType="pubmed">18406080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rumah K.R., Linden J., Fischetti V.A., Vartanian T. Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease. PLoS ONE. 2013;8:e76359.  doi: 10.1371/journal.pone.0076359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0076359</ArticleId>
            <ArticleId IdType="pmc">PMC3797790</ArticleId>
            <ArticleId IdType="pubmed">24146858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Linden J.R., Ma Y., Zhao B., Harris J.M., Rumah K.R., Schaeren-Wiemers N., Vartanian T. Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination. mBio. 2015;6:e02513. doi: 10.1128/mBio.02513-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.02513-14</ArticleId>
            <ArticleId IdType="pmc">PMC4471556</ArticleId>
            <ArticleId IdType="pubmed">26081637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wioland L., Dupont J., Doussau F., Gaillard S., Heid F., Isope P., Pauillac S., Popoff M., Bossu J., Poulain B. Epsilon toxin from Clostridium perfringens acts on oligodendrocytes without forming pores, and causes demyelination. Cell. Microbiol. 2015;17:369–388. doi: 10.1111/cmi.12373.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cmi.12373</ArticleId>
            <ArticleId IdType="pubmed">25287162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ivie S., McClain M. Identification of Amino Acids Important for Binding of Clostridium perfringens Epsilon Toxin to Host Cells and to HAVCR1. Biochemistry. 2012;51:7588–7595. doi: 10.1021/bi300690a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/bi300690a</ArticleId>
            <ArticleId IdType="pmc">PMC3534817</ArticleId>
            <ArticleId IdType="pubmed">22938730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fennessey C.M., Sheng J., Rubin D.H., McClain M.S. Oligomerization of Clostridium perfringens epsilon toxin is dependent upon caveolins 1 and 2. PLoS ONE. 2012;7:e46866.  doi: 10.1371/journal.pone.0046866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0046866</ArticleId>
            <ArticleId IdType="pmc">PMC3462777</ArticleId>
            <ArticleId IdType="pubmed">23056496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rumah K., Ma Y., Linden J., Oo M., Anrather J., Schaeren-Wiemers N., Alonso M., Fischetti V., McClain M., Vartanian T. The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens epsilon-Toxin. PLoS Pathog. 2015;11:e1004896.  doi: 10.1371/journal.ppat.1004896.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1004896</ArticleId>
            <ArticleId IdType="pmc">PMC4439126</ArticleId>
            <ArticleId IdType="pubmed">25993478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blanch M., Dorca-Arevalo J., Not A., Cases M., de Aranda I., Martinez-Yelamos A., Martinez-Yelamos S., Solsona C., Blasi J. The Cytotoxicity of Epsilon Toxin from Clostridium perfringens on Lymphocytes Is Mediated by MAL Protein Expression. Mol. Cell. Biol. 2018;38:e00086-18. doi: 10.1128/MCB.00086-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.00086-18</ArticleId>
            <ArticleId IdType="pmc">PMC6146834</ArticleId>
            <ArticleId IdType="pubmed">29987189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Linden J., Flores C., Schmidt E., Uzal F., Michel A., Valenzuela M., Dobrow S., Vartanian T. Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires expression of MAL. PLoS Pathog. 2019;15:e1008014.  doi: 10.1371/journal.ppat.1008014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1008014</ArticleId>
            <ArticleId IdType="pmc">PMC6867657</ArticleId>
            <ArticleId IdType="pubmed">31703116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petit L., Gibert M., Gillet D., Laurent-Winter C., Boquet P., Popoff M.R. Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex. J. Bacteriol. 1997;179:6480–6487. doi: 10.1128/jb.179.20.6480-6487.1997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jb.179.20.6480-6487.1997</ArticleId>
            <ArticleId IdType="pmc">PMC179566</ArticleId>
            <ArticleId IdType="pubmed">9335299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorca-Arévalo J., Martín-Satué M., Blasi J. Characterization of the high affinity binding of epsilon toxin from Clostridium perfringens to the renal system. Vet. Microbiol. 2012;157:179–189. doi: 10.1016/j.vetmic.2011.12.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetmic.2011.12.020</ArticleId>
            <ArticleId IdType="pubmed">22264388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorca-Arevalo J., Blanch M., Pradas M., Blasi J. Epsilon toxin from Clostridium perfringens induces cytotoxicity in FRT thyroid epithelial cells. Anaerobe. 2018;53:43–49. doi: 10.1016/j.anaerobe.2018.05.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.anaerobe.2018.05.011</ArticleId>
            <ArticleId IdType="pubmed">29895394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorca-Arevalo J., Dorca E., Torrejon-Escribano B., Blanch M., Martin-Satue M., Blasi J. Lung endothelial cells are sensitive to epsilon toxin from Clostridium perfringens. Vet. Res. 2020;51:27. doi: 10.1186/s13567-020-00748-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13567-020-00748-2</ArticleId>
            <ArticleId IdType="pmc">PMC7041264</ArticleId>
            <ArticleId IdType="pubmed">32093740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petit L., Gibert M., Gourch A., Bens M., Vandewalle A., Popoff M.R. Clostridium perfringens epsilon toxin rapidly decreases membrane barrier permeability of polarized MDCK cells. Cell. Microbiol. 2003;5:155–164. doi: 10.1046/j.1462-5822.2003.00262.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1462-5822.2003.00262.x</ArticleId>
            <ArticleId IdType="pubmed">12614459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cole A., Gibert M., Popoff M., Moss D., Titball R., Basak A. Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin. Nat. Struct. Mol. Biol. 2004;11:797–798. doi: 10.1038/nsmb804.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nsmb804</ArticleId>
            <ArticleId IdType="pubmed">15258571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Savva C., Clark A., Naylor C., Popoff M., Moss D., Basak A., Titball R., Bokori-Brown M. The pore structure of Clostridium perfringens epsilon toxin. Nat. Commun. 2019;10:2641. doi: 10.1038/s41467-019-10645-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-019-10645-8</ArticleId>
            <ArticleId IdType="pmc">PMC6572795</ArticleId>
            <ArticleId IdType="pubmed">31201325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alves G., de Avila R., Chavez-Olortegui C., Lobato F. Clostridium perfringens epsilon toxin: The third most potent bacterial toxin known. Anaerobe. 2014;30:102–107. doi: 10.1016/j.anaerobe.2014.08.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.anaerobe.2014.08.016</ArticleId>
            <ArticleId IdType="pubmed">25234332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pelish T., McClain M. Dominant-negative Inhibitors of the Clostridium perfringens epsilon-Toxin. J. Biol. Chem. 2009;284:29446–29453. doi: 10.1074/jbc.M109.021782.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M109.021782</ArticleId>
            <ArticleId IdType="pmc">PMC2785577</ArticleId>
            <ArticleId IdType="pubmed">19720828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oyston P., Payne D., Havard H., Williamson E., Titball R. Production of a non-toxic site-directed mutant of Clostridium perfringens epsilon-toxin which induces protective immunity in mice. Microbiology. 1998;144:333–341. doi: 10.1099/00221287-144-2-333.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/00221287-144-2-333</ArticleId>
            <ArticleId IdType="pubmed">9493371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morcrette H., Bokori-Brown M., Ong S., Bennett L., Wren B., Lewis N., Titball R. Clostridium perfringens epsilon toxin vaccine candidate lacking toxicity to cells expressing myelin and lymphocyte protein. NPJ Vaccines. 2019;4:32. doi: 10.1038/s41541-019-0128-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41541-019-0128-2</ArticleId>
            <ArticleId IdType="pmc">PMC6667452</ArticleId>
            <ArticleId IdType="pubmed">31372245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tamai E., Ishida T., Miyata S., Matsushita O., Suda H., Kobayashi S., Sonobe H., Okabe A. Accumulation of Clostridium perfringens epsilon-toxin in the mouse kidney and its possible biological significance. Infect. Immun. 2003;71:5371–5375. doi: 10.1128/IAI.71.9.5371-5375.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.71.9.5371-5375.2003</ArticleId>
            <ArticleId IdType="pmc">PMC187324</ArticleId>
            <ArticleId IdType="pubmed">12933886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soler-Jover A., Blasi J., Gómez de Aranda I., Navarro P., Gibert M., Popoff M.R., Martín-Satué M. Effect of epsilon toxin-GFP on MDCK cells and renal tubules in vivo. J. Histochem. Cytochem. 2004;52:931–942. doi: 10.1369/jhc.4A6254.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1369/jhc.4A6254.2004</ArticleId>
            <ArticleId IdType="pubmed">15208360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Engel U., Breborowicz D., Bøg-Hansen T., Francis D. Lectin staining of renal tubules in normal kidney. APMIS. 1997;105:31–34. doi: 10.1111/j.1699-0463.1997.tb00536.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1699-0463.1997.tb00536.x</ArticleId>
            <ArticleId IdType="pubmed">9063498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yabuki A., Suzuki S., Matsumoto M., Nishinakagawa H. Lectin-histochemical and -cytochemical study of periodic acid Schiff-positive lysosome granules as a histological feature of the female mouse kidney. Histol. Histopathol. 2002;17:1017–1024. doi: 10.14670/HH-17.1017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14670/HH-17.1017</ArticleId>
            <ArticleId IdType="pubmed">12371128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elger M., Werner A., Herter P., Kohl B., Kinne R.K., Hentschel H. Na-P(i) cotransport sites in proximal tubule and collecting tubule of winter flounder (Pleuronectes americanus) Am. J. Physiol. 1998;274:F374–F383. doi: 10.1152/ajprenal.1998.274.2.F374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.1998.274.2.F374</ArticleId>
            <ArticleId IdType="pubmed">9486233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jemal D., Shifa M., Kebede B. Review on Pulpy Kidney Disease. J. Vet. Sci. Technol. 2016;7:361. doi: 10.4172/2157-7579.1000361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4172/2157-7579.1000361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koppelman M., Dufau M. Prolactin receptors in luteinized rat ovaries—unmasking of specific binding-sites with detergent treatment. Endocrinology. 1982;111:1350–1357. doi: 10.1210/endo-111-4-1350.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/endo-111-4-1350</ArticleId>
            <ArticleId IdType="pubmed">6288358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mello R., Brown M., Goldstein J., Anderson R. LDL receptors in coated vesicles isolated from bovine adrenal-cortex—Binding-sites unmasked by detergent treatment. Cell. 1980;20:829–837. doi: 10.1016/0092-8674(80)90329-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(80)90329-3</ArticleId>
            <ArticleId IdType="pubmed">6251975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pilch P., Shia M., Benson R., Fine R. Coated vesicles participate in the receptor-mediated endocytosis of insulin. J. Cell Biol. 1983;96:133–138. doi: 10.1083/jcb.96.1.133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.96.1.133</ArticleId>
            <ArticleId IdType="pmc">PMC2112276</ArticleId>
            <ArticleId IdType="pubmed">6131074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunter S., Clarke I., Kelly D., Titball R. Cloning and nucleotide sequencing of the Clostridium-perfringens epsilon-toxin gene and its expression in escherichia-coli. Infect. Immun. 1992;60:102–110. doi: 10.1128/iai.60.1.102-110.1992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/iai.60.1.102-110.1992</ArticleId>
            <ArticleId IdType="pmc">PMC257509</ArticleId>
            <ArticleId IdType="pubmed">1729175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egea G., Goldstein I., Roth J. Light and electron-microscopic detection of (3-gal-beta-1,4 glcnac-beta-1) sequences in asparagine-linked oligosaccharides with the datura-stramonium lectin. Histochemistry. 1989;92:515–522. doi: 10.1007/BF00524763.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00524763</ArticleId>
            <ArticleId IdType="pubmed">2807997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laitinen L., Virtanen I., Saxen L. Changes in the glycosylation pattern during embryonic development of mouse kidney as revealed with lectin conjugates. J. Histochem. Cytochem. 1987;35:55–65. doi: 10.1177/35.1.3794309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/35.1.3794309</ArticleId>
            <ArticleId IdType="pubmed">3794309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukuda M. Beta-elimination for release of O-GalNAc-linked oligosaccharides from glycoproteins and glycopeptides. Curr. Protoc. Mol. Biol. 2001;31:17.15.4–17.15.9. doi: 10.1002/0471142727.mb1715bs31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/0471142727.mb1715bs31</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishimoto K., Tanaka K., Murakami T., Nakashita H., Sakamoto H., Oguri S. Datura stramonium agglutinin: Cloning, molecular characterization and recombinant production in Arabidopsis thaliana. Glycobiology. 2015;25:157–169. doi: 10.1093/glycob/cwu098.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/glycob/cwu098</ArticleId>
            <ArticleId IdType="pubmed">25246348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poiroux G., Barre A., van Damme E., Benoist H., Rouge P. Plant Lectins Targeting O-Glycans at the Cell Surface as Tools for Cancer Diagnosis, Prognosis and Therapy. Int. J. Mol. Sci. 2017;18:1232.  doi: 10.3390/ijms18061232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms18061232</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
